Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
PIRAMAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 32.7622.4916.66--

What is the latest Price to Cash Earnings (PCE) ratio of PIRAMAL PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of PIRAMAL PHARMA is 32.76 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202532.76
Mar202422.49
Mar202316.66
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of PIRAMAL PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 32.76
45.66
Mar2024 22.49
34.99
Mar2023 16.66
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹21,553.0 Cr 1.1% 5.5% -26.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,185.0 Cr 3.5% 12.3% 5.6% Stock Analytics
DIVIS LABORATORIES ₹171,766.0 Cr 2.8% 7.2% 7.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,923.0 Cr 3.8% 12.1% 42.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,081.0 Cr 3% 9.1% 11.6% Stock Analytics
CIPLA ₹109,680.0 Cr 1.2% 2.8% -9.1% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

1.1%

5.5%

-26.2%

SENSEX

-0.3%

-0.1%

8.3%


You may also like the below Video Courses